Norris Medicines Ltd.
Snapshot View

View in App

Prices View details >>

11.11 0.00

21 March 2023, 04:00:00 PM
Volume: 311

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.norrispharma.com
Market Cap 11.11 Cr.
Enterprise Value(EV) 32.62 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -3.44 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-12
Industry PE 31.70 Trailing Twelve Months Ending 2022-12
Book Value / Share -11.82 Trailing Twelve Months Ending 2022-12
Price to Book Value -0.94 Calculated using Price: 11.11
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.00 Cr. 10,000,700 Shares
FaceValue 10
Company Profile
The business area of the company is manufacturing of Injections and Medicinal formulations.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
-8.93%
1 Month
-13.88%
3 Month
-17.03%
6 Month
-21.37%
1 Year
-68.21%
2 Year
+77.19%
5 Year
-15.32%
10 Year

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -20.54 -17.93 0.71 -15.52 -76.01 -138.44
Return on Capital Employed (%) -14.70 3.99 4.06 -4.06 -17.04 -9.18 -18.63 -17.87 -6.59
Return on Assets (%) -7.17 -5.80 0.23 -4.18 -13.07 -9.37 -16.48 -29.19 -21.99

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 6 5 5 5 2 0 -2 -7 -11 -12
Non Curr. Liab. 5 6 6 6 5 8 11 13 16 17
Curr. Liab. 8 5 5 10 11 9 8 12 7 8
Minority Int.
Equity & Liab. 19 17 17 20 18 18 17 17 13 13
Non Curr. Assets 10 10 10 11 11 10 9 9 8 8
Curr. Assets 9 7 7 9 8 7 7 8 4 5
Misc. Exp. not W/O
Total Assets 19 17 17 20 18 18 17 17 13 13

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 21 19 19 20 14 16 8 12 9 8
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 21 19 19 21 14 16 8 12 9 8
Total Expenditure -22 -17 -18 -21 -15 -17 -10 -14 -10 -8
PBIDT -1 2 1 0 -2 -1 -2 -2 0 0
Interest 0 -1 -1 -1 -1 -1 -1 -2 -1 -1
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation 1 -1 0 0 1 0 1 -1 -1 -1
Exceptional Items
PAT -1 -1 0 -1 -3 -2 -3 -5 -3 -3
Adjusted EPS -1 -1 0 -1 -3 -2 -3 -5 -3 -3

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -1 1 1 1 -1 1 -2 -3 1 -1
Cash Fr. Inv. -1 -2 -1 0 -2 0 0 0 0
Cash Fr. Finan. 2 0 0 -1 3 -1 2 3 -1 1
Net Change 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 1 0 0 0 0 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 34.04 34.04 34.04 34.04 34.04 34.04 34.04 34.04 34.04
Public 65.96 65.96 65.96 65.96 65.96 65.96 65.96 65.96 65.96
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 02 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Submission of Reg. 39(3) - Details of Loss of Certificate / Duplicate Certificate
Mon, 13 Feb 2023
Outcome Of The Board Meeting Held Today And Financial Results For Dec 31 2022.
Outcome of the Board Meeting held today and Financial Results for Dec 31 2022.
Tue, 07 Feb 2023
Board Meeting Intimation for December Quarter Results
NORRIS MEDICINES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve 1. To consider and take on record the Un-audited Financial Results of the Company for quarter and nine months ended 31st December 2022. 2. Any other business with the permission of the Chair.

Technical Scans View Details >>

Tue, 21 Mar 2023
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Close Below Last Month Low Close Below Last Month Low
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 229,424.41 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. 73,593.21 4,419.30 -0.5%
Divi's Laboratories Ltd. 73,553.38 2,773.45 -0.9%
Cipla Ltd. 69,632.88 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. 61,491.67 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. 51,277.87 1,518.00 -0.3%
Zydus Lifesciences Ltd. 48,378.30 477.95 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 54.47 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.20 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 30.72 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-12 26.39 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.34 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.82 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.47 477.95 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.15 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.34 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 5.92 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-12 3.07 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.96 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.06 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.80 477.95 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-03 0.04 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 477.95 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-03 13.10 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 477.95 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-03 13.10 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 477.95 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-03 21,763.34 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 477.95 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-03 2,559.47 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 477.95 +0.4%

FAQ's On Norris Medicines Ltd.

What is Norris Medicines share price?
Can I buy Norris Medicines shares now?
What is the Market Cap of Norris Medicines?
What is the 52 Week High and Low of Norris Medicines?
What is the trend of Norris Medicines share price?